...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    vrax-img

    Virax Biolabs Group Limited Ordinary Shares, Common Stock

    VRAX

    NAQ

    $0.8836

    -$0.04

    (-4.32%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $4.02M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     310.63K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     1.64
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $0.74 L
    $7.63 H
    $0.8836

    About Virax Biolabs Group Limited Ordinary Shares, Common Stock

    Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameVRAXSectorS&P500
    1-Week Return-11.24%-1.35%0.18%
    1-Month Return11.57%-0.27%2.8%
    3-Month Return-9.86%-4.3%14.55%
    6-Month Return-47.72%-8.76%4.96%
    1-Year Return-29.31%-10.49%17.23%
    3-Year Return-99.25%2.29%54.62%
    5-Year Return-99.51%26.65%96.2%

    Financials

    Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
    Total Revenue123.82K-8.56K156.42K6.33K[{"date":"2021-03-31","value":79.16,"profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":5.47,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":4.05,"profit":true}]
    Cost of Revenue133.25K-9.93K105.83K59.40K[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":7.45,"profit":true},{"date":"2024-03-31","value":79.42,"profit":true},{"date":"2025-03-31","value":44.58,"profit":true}]
    Gross Profit(9.43K)-(1.36K)50.59K(53.07K)[{"date":"2021-03-31","value":-18.65,"profit":false},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":-2.7,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-104.9,"profit":false}]
    Gross Margin(7.62%)-(15.94%)32.34%(838.21%)[{"date":"2021-03-31","value":-23.56,"profit":false},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":-49.3,"profit":false},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":-2591.65,"profit":false}]
    Operating Expenses635.10K1.73M5.73M6.55M6.11M[{"date":"2021-03-31","value":9.7,"profit":true},{"date":"2022-03-31","value":26.48,"profit":true},{"date":"2023-03-31","value":87.54,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":93.32,"profit":true}]
    Operating Income(644.54K)(1.73M)(5.73M)(6.50M)(6.16M)[{"date":"2021-03-31","value":-64454000,"profit":false},{"date":"2022-03-31","value":-173368000,"profit":false},{"date":"2023-03-31","value":-573276000,"profit":false},{"date":"2024-03-31","value":-649647300,"profit":false},{"date":"2025-03-31","value":-616289700,"profit":false}]
    Total Non-Operating Income/Expense(57.02K)(31.63K)259.53K(269.52K)(99.17K)[{"date":"2021-03-31","value":-21.97,"profit":false},{"date":"2022-03-31","value":-12.19,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-103.85,"profit":false},{"date":"2025-03-31","value":-38.21,"profit":false}]
    Pre-Tax Income(672.91K)(1.75M)(5.46M)(6.74M)(6.20M)[{"date":"2021-03-31","value":-67291500,"profit":false},{"date":"2022-03-31","value":-174987000,"profit":false},{"date":"2023-03-31","value":-545776300,"profit":false},{"date":"2024-03-31","value":-673912000,"profit":false},{"date":"2025-03-31","value":-620389300,"profit":false}]
    Income Taxes(666.47K)(1.77M)(271.00)(194.47K)(136.66K)[{"date":"2021-03-31","value":-66646900,"profit":false},{"date":"2022-03-31","value":-177472200,"profit":false},{"date":"2023-03-31","value":-27100,"profit":false},{"date":"2024-03-31","value":-19447400,"profit":false},{"date":"2025-03-31","value":-13666100,"profit":false}]
    Income After Taxes(6.45K)24.85K(5.46M)(6.54M)(6.07M)[{"date":"2021-03-31","value":-25.94,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-21959.97,"profit":false},{"date":"2024-03-31","value":-26334.48,"profit":false},{"date":"2025-03-31","value":-24413.46,"profit":false}]
    Income From Continuous Operations(672.91K)(1.75M)(5.46M)(6.74M)(6.07M)[{"date":"2021-03-31","value":-67291500,"profit":false},{"date":"2022-03-31","value":-174987000,"profit":false},{"date":"2023-03-31","value":-545776300,"profit":false},{"date":"2024-03-31","value":-673912000,"profit":false},{"date":"2025-03-31","value":-606723200,"profit":false}]
    Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
    Net Income(650.98K)(1.71M)(5.46M)(6.73M)(6.06M)[{"date":"2021-03-31","value":-65098400,"profit":false},{"date":"2022-03-31","value":-170882700,"profit":false},{"date":"2023-03-31","value":-545749400,"profit":false},{"date":"2024-03-31","value":-673353700,"profit":false},{"date":"2025-03-31","value":-606124700,"profit":false}]
    EPS (Diluted)-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    VRAX
    Cash Ratio 6.28
    Current Ratio 7.27
    Quick Ratio 7.13

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    VRAX
    ROA (LTM) -64.68%
    ROE (LTM) -114.47%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    VRAX
    Debt Ratio Lower is generally better. Negative is bad. 0.15
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.89

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    VRAX
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 635.69
    P/B 0.42
    Price/FCF NM
    EV/R 27.27
    EV/Ebitda 0.42

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Virax Biolabs Group Limited Ordinary Shares share price today?

    Virax Biolabs Group Limited Ordinary Shares (VRAX) share price today is $0.8836

    Can Indians buy Virax Biolabs Group Limited Ordinary Shares shares?

    Yes, Indians can buy shares of Virax Biolabs Group Limited Ordinary Shares (VRAX) on Vested. To buy Virax Biolabs Group Limited Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VRAX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Virax Biolabs Group Limited Ordinary Shares be purchased?

    Yes, you can purchase fractional shares of Virax Biolabs Group Limited Ordinary Shares (VRAX) via the Vested app. You can start investing in Virax Biolabs Group Limited Ordinary Shares (VRAX) with a minimum investment of $1.

    How to invest in Virax Biolabs Group Limited Ordinary Shares shares from India?

    You can invest in shares of Virax Biolabs Group Limited Ordinary Shares (VRAX) via Vested in three simple steps:

    • Click on Sign Up or Invest in VRAX stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Virax Biolabs Group Limited Ordinary Shares shares
    What is Virax Biolabs Group Limited Ordinary Shares 52-week high and low stock price?

    The 52-week high price of Virax Biolabs Group Limited Ordinary Shares (VRAX) is $7.63. The 52-week low price of Virax Biolabs Group Limited Ordinary Shares (VRAX) is $0.74.

    What is Virax Biolabs Group Limited Ordinary Shares price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Virax Biolabs Group Limited Ordinary Shares (VRAX) is 0.42

    What is the Market Cap of Virax Biolabs Group Limited Ordinary Shares?

    The market capitalization of Virax Biolabs Group Limited Ordinary Shares (VRAX) is $4.02M

    What is Virax Biolabs Group Limited Ordinary Shares’s stock symbol?

    The stock symbol (or ticker) of Virax Biolabs Group Limited Ordinary Shares is VRAX

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top